Leiomyosarcoma of the rectum: What role does adjuvant therapy play?

Authors: Kiffer, John D¹; Castles, Lindsay¹; Quong, George G¹; Feigen, Malcolm¹

Source: Australasian Radiology, Volume 43, Number 2, May 1999 , pp. 262-265(4)

Publisher: Blackwell Publishing

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Leiomyosarcoma of the rectum is an exceedingly rare malignancy and for this reason the literature fails to provide definitive management guidelines with regard to the place of adjuvant therapies. The role of radiotherapy (RT) is often downplayed on the basis of articles written at a time when state-of-the art RT equipment was unavailable. A case of leiomyosarcoma of the rectum is presented and the literature is reviewed. Because the rarity of this tumour type virtually precludes a prospective randomized trial of adjuvant therapies, the authors recommend (in otherwise fit patients) postoperative pelvic RT because its morbidity is minimal. Smaller tumours may benefit to a greater extent than those lesions that are large at presentation and thereby run a worse clinical course.

Keywords: leiomyosarcoma; radiotherapy; rectum

Document Type: Research article

DOI: 10.1046/j.1440-1673.1999.00646.x

Affiliations: 1: Austin and Repatriation Medical Centre, Repatriation Campus, West Heidelberg, Victoria, Australia

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax Refund Policy